Tag Archives: Elinzanetant
25
Jul
FDA extends review period for Bayer’s elinzanetant for vasomotor symptoms
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms | Image credit: Contempora...
27
Jun
Elinzanetant in Breast Cancer Care
Effectively managing adverse effects associated with endocrine therapy is crucial, as it directly in...
03
Jun
Elinzanetant found to reduce VMS from endocrine therapy for breast cancer
Elinzanetant found to reduce VMS from endocrine therapy for breast cancer | Image Credit: © highways...
16
May
Elinzanetant reduces vasomotor symptom frequency and intensity in new meta-analysis
Elinzanetant reduces vasomotor symptom frequency and intensity in new meta-analysis| Image Credit: ©...